These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4410914)

  • 21. Single-agent therapy for Hodgkin's disease.
    Carter SK; Livingston RB
    Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
    Klumb CE; Carriço MK; de Rezende LM; Byington R; Bordallo MA; Bigni RS; Apa AG; Dobbin JA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):628-9. PubMed ID: 17662581
    [No Abstract]   [Full Text] [Related]  

  • 23. [Malignant lymphoma].
    Streuli RA
    Schweiz Rundsch Med Prax; 1981 May; 70(20):909-15. PubMed ID: 7015304
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cytostatic chemotherapy in lymphogranulomatosis].
    Dold U
    Minerva Med; 1978 Nov; 69(58):4002-7. PubMed ID: 740293
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT
    Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
    [No Abstract]   [Full Text] [Related]  

  • 26. [Myocardial infarct, acute coronary insufficiency and sudden death in lymphogranulomatosis patients after irradiation of the mediastinum].
    Baĭsogolov GD; Shishkin IP
    Radiobiol Radiother (Berl); 1983; 24(2):165-70. PubMed ID: 6688135
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 28. [Functional state of the liver in lymphogranulomatosis during drug and radiation treatment].
    Danova LA; Filov VA
    Vopr Onkol; 1972; 18(10):43-7. PubMed ID: 4662532
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 30. Reversal of myelofibrosis in Hodgkin disease.
    Viola MV; Kovi J; Nukhopadhyay M
    JAMA; 1973 Mar; 223(10):1145-6. PubMed ID: 4739373
    [No Abstract]   [Full Text] [Related]  

  • 31. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
    Gibbs GE; Peterson BA; Kennedy BJ; Vosika G; Bloomfield CD
    Arch Intern Med; 1981 Jun; 141(7):897-900. PubMed ID: 7235809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of neoplasms with partial synchronization of cell proliferation].
    Jedrzejczak W; Siekierzyński M
    Pol Tyg Lek; 1974 Mar; 29(11):461-3. PubMed ID: 4822190
    [No Abstract]   [Full Text] [Related]  

  • 35. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
    Josting A; Nogová L; Franklin J; Glossmann JP; Eich HT; Sieber M; Schober T; Boettcher HD; Schulz U; Müller RP; Diehl V; Engert A
    J Clin Oncol; 2005 Mar; 23(7):1522-9. PubMed ID: 15632410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
    Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combined chemotherapy in disseminated Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1972 Jul; 27(24):927-9. PubMed ID: 4557231
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Hodgkin's disease].
    Brule G
    Arq Patol; 1974; 46(2-3):273-7. PubMed ID: 4458640
    [No Abstract]   [Full Text] [Related]  

  • 40. Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report.
    Basić-Jukić N; Radman I; Roncević T; Jakić-Razumović J
    Croat Med J; 2002 Oct; 43(5):573-5. PubMed ID: 12402399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.